ESC 365 - Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - pro

ESC2024 Premium Access

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - pro

Session: Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?

Topic: Cardiovascular Disease in Women

Speaker: Associate Professor C. Gebhard (Bern, CH)

Event: ESC Congress 2024

Congress Presentation

About the speaker

Associate Professor Catherine Gebhard

Inselspital - University of Bern, Bern (Switzerland)

4 presentations

0 follower

2 more presentations in this session

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - con

Speaker: Professor M. Gulati (Los Angeles, US)

Should all menopausal women be prescribed hormone replacement therapy to reduce risk? - discussion

Access the full session

Great Debate: should all menopausal women be prescribed hormone replacement therapy to reduce risk?

Speakers: Associate Professor C. Gebhard, Professor M. Gulati

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources